US FDA Advisory Committee Formats Can Spur Unhealthy Dynamics – Califf

 
• By Sarah Karlin-Smith
five people with same "thinking" bubble
FDA thinking about how to curtail problematic group dynamics during advisory panels. • Source: Shutterstock

More from Rx-to-OTC Switch

More from Health